Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125309681 | 12530968 | 1 | I | 20160627 | 20160706 | 20160706 | EXP | TR-BAXTER-2016BAX035961 | BAXTER | YILMAZ N, EMMUNGIL H, GUCENMEZ S, OZEN G, YILDIZ F, BALKARLI A, KIMYON G, COSKUN B, DOGAN I, PAMUK O, YASAR S, CETIN G, YAZICI A, ESMEN S, CAGATAY Y, YILMAZ S, CEFLE A, SAYARLIOGLU M, KASIFOGLU T, KARADAG O, PEHLIVAN Y, DALKILIC E, KISACIK B, COBANKARA V, ERKEN E, DIRESKENELI H, AKSU K, YAVUZ S. INCIDENCE OF CYCLOPHOSPHAMIDE-INDUCED UROTOXICITY AND PROTECTIVE EFFECT OF MESNA IN RHEUMATIC DISEASES. JOURNAL OF RHEUMATOLOGY. 2015 JAN 01;42 (9):1661-1666. | 0.00 | A | Y | 0.00000 | 20160706 | MD | TR | TR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125309681 | 12530968 | 1 | SS | UROMITEXAN 400 MG/4 ML. (MESNA) | MESNA | 1 | Intravenous (not otherwise specified) | 20-40% OF CYCLOPHOSPHAMIDE DOSE | U | 0 | SOLUTION FOR INJECTION | ||||||||
125309681 | 12530968 | 2 | PS | ENDOXAN 1G. IV | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 0.5-0.6 G/M2, EVERY 2-4 WEEKS | U | 12142 | POWDER FOR SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125309681 | 12530968 | 1 | Prophylaxis |
125309681 | 12530968 | 2 | Rheumatic disorder |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125309681 | 12530968 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125309681 | 12530968 | Cystitis haemorrhagic |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |